TScan Therapeutics, Inc. (TCRX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $4.41M | +15.2% |
| 2024 | $3.83M | +21.6% |
| 2023 | $3.15M | -25.5% |
| 2022 | $4.22M | -57.5% |
| 2021 | $9.94M | +134.6% |
| 2020 | $4.24M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $4.41M | +15.2% |
| 2024 | $3.83M | +21.6% |
| 2023 | $3.15M | -25.5% |
| 2022 | $4.22M | -57.5% |
| 2021 | $9.94M | +134.6% |
| 2020 | $4.24M | — |